Introduction to Lost in Translation

Within the past six months, a fifth patient developed a lympho-proliferative disorder in an X-SCID gene transfer trial. The RAC has all but cleared AAV vector as a causal agent in the death of Jolee Mohr in a rheumatoid arthritis study. A Merck HIV-vaccine trial involving adenoviral vectors was terminated after a data safety monitoring board found that volunteers receiving placebo had lower rates of sero-conversion.

I created this blog to establish a forum to report and comment on developments in gene transfer—and other areas of translational clinical research— that raise interesting or important ethical questions. The first several posts will contain some introductory material that provides definitions and describes the scope of this blog.

2008 February 6 | Leave a comment | Tags: Introductory material

BibTeX

@Manual{stream2008-187,
    title = {Introduction to Lost in Translation},
    journal = {STREAM research},
    author = {Jonathan Kimmelman},
    address = {Montreal, Canada},
    date = 2008,
    month = feb,
    day = 6,
    url = {http://www.translationalethics.com/2008/02/06/introduction-to-lost-in-translation/}
}

MLA

Jonathan Kimmelman. "Introduction to Lost in Translation" Web blog post. STREAM research. 06 Feb 2008. Web. 05 Dec 2024. <http://www.translationalethics.com/2008/02/06/introduction-to-lost-in-translation/>

APA

Jonathan Kimmelman. (2008, Feb 06). Introduction to Lost in Translation [Web log post]. Retrieved from http://www.translationalethics.com/2008/02/06/introduction-to-lost-in-translation/

Tweet this post

Introduction to Lost in Translation

Leave a Reply Cancel reply

Search STREAM